Skip to main content
Caplight Logo









EQGen Biomedical

EQGen Biomedical

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.eqgenbiomed.com/

Last Round

Seed

Apr 24, 2025

Total Funding Raised

$3.7M

Company Overview

EQGen Biomedical is a biotechnology company that develops regenerative stem cell therapies for the treatment of musculoskeletal diseases in animals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

veterinary biotechnologyregenerative medicinestem cell therapymesenchymal stem cellsallogeneic therapyanimal healthequine osteoarthritisveterinary orthopedicscell selection technologyvet biotechpet regenerative medicinemusculoskeletal diseaseclinical developmentanimal pharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EQGen Biomedical Comparables

Compare EQGen Biomedical with similar companies based on industry and business-model similarity.

EQGen Biomedical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
eQcell Inc.
86%
Qentoros, Inc.
83%
EquiCord
82%

EQGen Biomedical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 24, 2025

Key People

Founding team and executive leadership

Willem H. Scheele

President, Founder and Chief Medical Officer

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 24, 2025

    $4M raised from Grant Senner and Willem Scheele.

EQGen Biomedical Filings

Explore SEC and related filing metadata, where available.

EQGen Biomedical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EQGen Biomedical's valuation, stock price, and market status.

Is EQGen Biomedical a public or private company?

EQGen Biomedical is a private company.

What is the current stock price of EQGen Biomedical?

EQGen Biomedical is a private company with no public stock price. Caplight tracks EQGen Biomedical's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is EQGen Biomedical worth (valuation)?

Valuation information for EQGen Biomedical is not publicly available.

Can I buy EQGen Biomedical stock?

EQGen Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EQGen Biomedical's last funding round?

EQGen Biomedical's most recent funding round was Seed on April 24, 2025.

Who are the main investors in EQGen Biomedical?

Investor information for EQGen Biomedical is not publicly disclosed.

Will EQGen Biomedical IPO soon?

No public IPO plans have been announced for EQGen Biomedical.

How can I track EQGen Biomedical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EQGen Biomedical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range3
Year Founded2024
Last FundingApr 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?